Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entity is an uncharacterized antisense transcript overlapping the FAM49B gene—a gene that encodes a cytoskeleton regulator implicated in cell proliferation, immune response, and possibly cancer progression[2]. Antisense RNAs in general can modulate the chromatin landscape and sense mRNA dynamics, often via epigenetic mechanisms[1]. However, there is currently no detailed characterization of the molecular function, regulatory effect, disease association, or pharmacological relevance of this specific transcript. Its utility as a drug target or biomarker is unsubstantiated, and its annotation may reflect preliminary transcriptomic data without functional validation.
Not established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to FAM49B (ENSG00000287195).